1. Nelen, M.R.; Kremer, H.; Konings, I.B.M.; Schoute, F.; van Essen, A.J.; Koch, R.; Woods, C.G.; Fryns, J.-P.; Hamel, B.; Hoefsloot, L.H.; Peeters, E.A.J.; Padberg, G.W.

Novel PTEN mutations in patients with Cowden disease: Absence of clear genotype-phenotype correlations. Eur. J. Hum. Genet. 1999, 7, 267-273. 11.

2. Li, J.; Yen, C.; Liaw, D.; Podsypanina, K.; Bose, S.; Wang, S.I.; Puc, J.; Miliaresis, C.; Rodgers, L.; McCombie, R.; Bigner, S.H.; Giovanella, B.C.; Ittman, M.; Tycko, B.; 12. Hibshoosh, H.; Wigler, M.H.; Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 1997,

275, 1943-1947.

3. Nelen, M.R.; Padberg, G.W.; Peeters, E.A.J.; Lin, A.Y.; 13. van den Helm, B.; Frants, R.R.; Coulon, V.; Goldstein,

A.M.; van Reen, M.M.M.; Easton, D.F.; Eeles, R.A.; Hodgson, S.; Mulvihill, J.J.; Murday, V.A.; Tucker, M.A.; Mairman, E.C.M.; Starink, T.M.; Ponder, B.A.J.; Ropers, H.H.; Kremer, H.; Longy, M.; Eng, C. Localization of the 14. gene for Cowden disease to chromosome 10q22-23. Nat. Genet. 1996, 13, 114-116.

4. Marsh, D.J.; Coulon, V.; Lunetta, K.L.; Rocca-Sera, P.; Dahia, P.L.M.; Zheng, Z.; Liaw, D.; Caron, S.; Duboue, 15.

B.; Lin, A.Y.; Richardson, A.-L.; Bonnetblanc, J.-M.; Bressieux, J.-M.; Cabarrot-Moreau, A.; Chompret, A.; Demange, L.; Eeles, R.A.; Yahanda, A.M.; Fearon, E.R.; Fricker, J.-P.; Gorlin, R.J.; Hodgson, S.V.; Huson, S.; Lacombe, D.; LePrat, F.; Odent, S.; Toulouse, C.; Olopade, 16. O.I.; Sobol, H.; Tishler, S.; Geoffrey, W.C.; Robinson,

B.G.; Weber, H.C.; Parsons, R.; Peacocke, M.; Longy, M.;

Eng, C. Mutation spectrum and genotype-phenotype 17 analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN 18 mutation. Hum. Mol. Genet. 1998, 7, 507-515.

5. Wirtzfeld, D.A.; Petrelli, N.J.; Rodriguez-Bigas, M.A. Hamartomatous polyposis syndromes: Molecular genetics, neoplastic risk, and surveillance recommendations. Ann. Surg. Oncol. 2001, 8, 319-327.

6. Marsh, D.J.; Zori, R.T. Genetic insights into familial cancers—Update and recent discoveries. Cancer Lett. 2002, 181, 125-164.

7. Hendriks, Y.M.C.; Verhallen, J.T.C.M.; van der Smagt,J.J.; 19. Kant, S.G.; Hilhorst, Y.; Hoefsloot, L.; Hansson, K.B.-M.;

van der Straaten, P.J.C.; Boutkan, H.; Breuning, M.H.; Vasen, H.F.A.; Brocker-Vriends, A.H.J.T. Bannayan-Riley-Ruvalcaba syndrome: Further delineation of the phenotype and management of PTEN mutation-positive 20 cases. Fam. Cancer 2003, 2, 79-85.

8. Starink, T.M.; van der Veen, J.P.W.; Arwert, F.; de Waal, L.P.; de Langge, G.G.; Gillie, J.J.P.; Eriksson, A.W. The Cowden syndrome: A clinical and genetic study in 21 patients. Clin. Genet. 1986, 29, 222-233 . 21.

9. Zori, R.T.; Marsh, D.J.; Graham, G.E.; Marliss, E.B.; Eng,

C. Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Am. J. Med. Genet. 1998, 80, 399-402. 22.

10. Marsh, D.J.; Kum, J.B.; Lunetta, K.L.; Bennet, M.J.; Gorlin, R.J.; Ahmed, F.; Bodurtha, J.; Crowe, C.; Curtis, M.A.; Dasouki, M.; Dunn, T.; Feit, H.; Geraghty, M.T.; Graham, J.M.; Hodgson, S.V.; Hunter, A.; Korf, B.R.; Manchester,

D.; Miesfeldt, S.; Murday, V.A.; Nathanson, K.L.; Parisi, 23. M.; Pober, B.; Romano, C.; Tolmie, J.L.; Trembath, R.; Winter, R.M.; Zackai, E.H.; Zori, R.T.; Weng, L.-P.; Dahia, 24. P.L.M.; Eng, C. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum. Mol. Genet. 1999, 8, 1461-1472. Eng, C. Will the real Cowden syndrome please stand up: Revised diagnostic criteria. J. Med. Genet. 2000, 37, 828830.

Marsh, D.J.; Dahia, P.L.M.; Caron, S.; Kum, J.B.; Frayling, I.M.; Tomlinson, I.P.M.; Hughes, K.S.; Eeles, R.A.; Hodgson, S.V.; Murday, V.A.; Houlston, R.; Eng, C. Germline PTEN mutations in Cowden syndrome-like families. J. Med. Genet. 1998, 35, 881-88. De Vivo, I.; Gertig, D.M.; Nagase, S.; Hankinson, S.E.; O'Brien, R.; Speizer, F.E.; Parsons, R.; Hunter, D.J. Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers. J. Med. Genet.

Tsubosa, Y.; Fukutomi, T.; Tsuda, H.; Kanai, Y.; Akashi-Tanaka, S.; Nanasawa, T.; Linuma, G.; Ushio, K. Breast cancer in Cowden's disease: A case report with review of the literature. Jpn. J. Oncol. 1998, 28, 42-46. Dahia, P.L.M.; Fitzgerald, M.J.; Zhang, X.; Marsh, D.J.; Zheng, Z.; Pietsch, T.; von Diemling, A.; Haluska, F.G.; Haber, D.A.; Eng, C. A highly conserved processed PTEN pseudogene is located on chromosome band 9p21. Oncogene 1998, 16, 2403-2406.

Zysman, M.A.; Chapman, W.B.; Bapat, B. Considerations when analysing the methylation status of PTEN tumor suppressor gene. Am. J. Pathol. 2002, 160, 795-800. Di Cristofano, A.; Pandolfi, P.P. The multiple roles of PTEN in tumour suppression. Cell 2002,100, 387-390. Zhou, X.-P.; Waite, K.A.; Pilarski, R.; Hampel, H.; Fernandez, M.J.; Bos, C.; Dasouki, M.; Feldman, G.L.; Greenberg, L.A.; Ivanovich, J.; Matloff, E.; Patterson, A.; Pierpont, M.E.; Russo, D.; Nassif, N.T.; Eng, C. Germline PTEN promoter mutations and deletions in Cowden/ Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am. J. Hum. Genet. 2003, 73, 404411.

Zhou, X.-P.; Marsh, D.J.; Morrison, C.D.; Chaudhury, A.R.; Maxwell, M.; Reifenberger, G.; Eng, C. Germline inactivation of PTEN and dysregulation of the phosphoi-nositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease. Am. J. Hum. Genet. 2003, 73, 1191-1198. Zhou, X.-P.; Hampel, H.; Thiele, H.; Gorlin, R.J.; Hennekam, R.C.M.; Parisi, M.; Winter, R.M.; Eng, C. Association of a germline mutation in the PTEN tumor suppressor gene and Proteus and Proteus-like syndromes. Lancet 2001, 358, 210-211.

Reardon, W.; Zhou, X.-P.; Eng, C. A novel germline mutation of the PTEN gene in a patient with macrocephaly, ventricular dilatation, and features of VATER association. J. Med. Genet. 2001, 38, 820-823. Marsh, D.J.; Theodosopoulos, G.; Howell, V.; Richardson, A.-L.; Benn, D.E.; Proos, A.L.; Eng, C.; Robinson, B.G. Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing HPLC. Neoplasia

Waite, K.A.; Eng, C. Protean PTEN: Form and function. Am. J. Hum. Genet. 2002, 70, 829-844. Barker, K.T.; Houlston, R.S. Overgrowth syndromes: Is dysfunctional PI3-kinase signalling a unifying mechanism? Eur. J. Hum. Genet. 2003, 11, 665-670.

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment